SI1396501T1 - Protitelesa za identifikacijo in/ali izolacijo najmanj ene celiäśne populacije, ki je izbrana iz skupine, ki obsega hematopoetske matiäśne celice, nevronske matiäśne celice, nevronske prekurzorske celice, mezenhimske matiäśne celice in mezenhimske pr - Google Patents

Protitelesa za identifikacijo in/ali izolacijo najmanj ene celiäśne populacije, ki je izbrana iz skupine, ki obsega hematopoetske matiäśne celice, nevronske matiäśne celice, nevronske prekurzorske celice, mezenhimske matiäśne celice in mezenhimske pr

Info

Publication number
SI1396501T1
SI1396501T1 SI200331812T SI200331812T SI1396501T1 SI 1396501 T1 SI1396501 T1 SI 1396501T1 SI 200331812 T SI200331812 T SI 200331812T SI 200331812 T SI200331812 T SI 200331812T SI 1396501 T1 SI1396501 T1 SI 1396501T1
Authority
SI
Slovenia
Prior art keywords
stem cells
cells
neuronal
mesenchymal
antibodies
Prior art date
Application number
SI200331812T
Other languages
English (en)
Inventor
Hans-Jorg Dr Buhring
Reiner Dr Lammers
Selim Dr Kuci
Tim Conze
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31502534&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1396501(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SI1396501T1 publication Critical patent/SI1396501T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SI200331812T 2002-09-04 2003-08-26 Protitelesa za identifikacijo in/ali izolacijo najmanj ene celiäśne populacije, ki je izbrana iz skupine, ki obsega hematopoetske matiäśne celice, nevronske matiäśne celice, nevronske prekurzorske celice, mezenhimske matiäśne celice in mezenhimske pr SI1396501T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10242146A DE10242146A1 (de) 2002-09-04 2002-09-04 Antikörper zur Identifizierung und/oder Isolierung von hämatopoetischen Stammzellen
EP03019221A EP1396501B1 (en) 2002-09-04 2003-08-26 Antibodies for identifying and/or isolating at least one cell population which is selected from the group comprising haematopoietic stem cells, neuronal stem cells, neuronal precursor cells, mesenchymal stem cells and mesenchymal precursor cells

Publications (1)

Publication Number Publication Date
SI1396501T1 true SI1396501T1 (sl) 2010-07-30

Family

ID=31502534

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200331812T SI1396501T1 (sl) 2002-09-04 2003-08-26 Protitelesa za identifikacijo in/ali izolacijo najmanj ene celiäśne populacije, ki je izbrana iz skupine, ki obsega hematopoetske matiäśne celice, nevronske matiäśne celice, nevronske prekurzorske celice, mezenhimske matiäśne celice in mezenhimske pr

Country Status (9)

Country Link
US (5) US7541030B2 (sl)
EP (2) EP1396501B1 (sl)
AT (1) ATE462728T1 (sl)
CY (1) CY1110144T1 (sl)
DE (2) DE10242146A1 (sl)
DK (1) DK1396501T3 (sl)
ES (1) ES2344982T3 (sl)
PT (1) PT1396501E (sl)
SI (1) SI1396501T1 (sl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10242338A1 (de) * 2002-09-09 2004-03-18 Eberhard-Karls-Universität Tübingen Universitätsklinikum Antikörper zur Isolierung und/oder Identifizierung mesenchymaler Stammzellen und Verfahren zur Isolierung und/oder Identifizierung mesenchymaler Stammzellen
KR100748363B1 (ko) * 2005-10-21 2007-08-09 삼성에스디아이 주식회사 점화장치를 갖는 연료개질 시스템
TWI412375B (zh) 2009-08-28 2013-10-21 Roche Glycart Ag 人類化抗ｃｄｃｐ１抗體
TW201113037A (en) * 2009-08-28 2011-04-16 Hoffmann La Roche Antibodies against CDCP1 for the treatment of cancer
KR101383090B1 (ko) * 2013-07-11 2014-04-08 주식회사 이바이오젠 액상 항원―항체 반응을 이용한 다량의 단백질 발현 분석 방법
WO2015082446A1 (en) 2013-12-02 2015-06-11 F. Hoffmann-La Roche Ag Treatment of cancer using an anti-cdcp1 antibody and a taxane
MX361695B (es) 2015-02-18 2018-12-13 Hoffmann La Roche Inmunoconjugados para la inducción específica de citotoxicidad de células t contra una célula blanco.
CN118562004A (zh) 2016-12-16 2024-08-30 蓝鳍生物医药公司 抗-含cub结构域蛋白1(cdcp1)抗体、抗体药物缀合物及其使用方法
US10928391B2 (en) * 2017-06-06 2021-02-23 The Cleveland Clinic Foundation CD318 as a marker for, and CD318 inhibition as a treatment for, autoimmune disease
CN118440202A (zh) * 2019-12-27 2024-08-06 凯奥目生物科学株式会社 抗cdcp1抗体
LU500787B1 (en) 2021-10-26 2023-04-27 Univ Hamburg Eppendorf Uke Isolation and detection of cdcp1 positive circulating tumor cells

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4844893A (en) * 1986-10-07 1989-07-04 Scripps Clinic And Research Foundation EX vivo effector cell activation for target cell killing
US6245898B1 (en) * 1998-06-15 2001-06-12 The Research Foundation Of State University Of New York Monoclonal antibodies that recognize antigens associated with tumor metastasis
JP2002521055A (ja) 1998-07-30 2002-07-16 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ９８個のヒト分泌タンパク質
EP1074617A3 (en) 1999-07-29 2004-04-21 Research Association for Biotechnology Primers for synthesising full-length cDNA and their use
CA2490909A1 (en) 1999-12-01 2001-06-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1285084A1 (en) 2000-01-25 2003-02-26 Hyseq, Inc. Novel nucleic acids and polypeptides
US6436703B1 (en) 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
US20020142003A1 (en) * 2000-07-07 2002-10-03 Norbert Schweifer Tumor-associated antigen (B345)
WO2002004508A1 (de) * 2000-07-07 2002-01-17 Boehringer Ingelheim International Gmbh Tumorassoziiertes antigen (b345), gekennzeichnet durch eine aminosäuresequenz wie in seq. id. no. 4
CA2787820A1 (en) * 2003-02-19 2004-09-02 Novartis Ag Glycoprotein antigen sima135 expressed in metastatic human tumor cells

Also Published As

Publication number Publication date
US20090181033A1 (en) 2009-07-16
DE10242146A1 (de) 2004-03-18
DK1396501T3 (da) 2010-06-21
EP1396501B1 (en) 2010-03-31
US7741114B2 (en) 2010-06-22
EP2206729A1 (en) 2010-07-14
US20040053343A1 (en) 2004-03-18
US7541030B2 (en) 2009-06-02
CY1110144T1 (el) 2015-01-14
US20150045541A1 (en) 2015-02-12
PT1396501E (pt) 2010-05-17
ES2344982T3 (es) 2010-09-13
DE60331882D1 (de) 2010-05-12
US20130267687A1 (en) 2013-10-10
ATE462728T1 (de) 2010-04-15
US20100179306A1 (en) 2010-07-15
EP1396501A1 (en) 2004-03-10

Similar Documents

Publication Publication Date Title
CY1110144T1 (el) Αντισωματα για την ταυτοποιηση και/ή την απομονωση τουλαχιστον ενος κυτταρικου πληθυσμου ο οποιος επιλεγεται απο την ομαδα την περιλαμβανουσα αιμοποιητικα βλαστοκυτταρα, νευρικα βλαστοκυτταρα, νευρικα αρχεγονα κυτταρα, μεσεγχυματικα βλαστοκυτταρα και μεσεγχυματικα αρχεγονα κυτταρα
EP2186884A3 (en) HCV-anti-core monoclonal antibody
RS80704A (en) ANTI- av?6.ANTIBODIES
NZ591636A (en) Sclerostin binding agents
AU3117201A (en) Methods and compositions for generating human monoclonal antibodies
NZ616992A (en) Anti-ilt7 antibody
WO2004029092A8 (fr) Anticorps pour adcc et induisant la production de cytokines.
UA89017C2 (uk) ЛЮДСЬКЕ АНТИТІЛО, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ЛЮДСЬКИМ TNFSF13b
MXPA06010673A (es) Reduccion del riesgo de anticuerpos humanos anti-humano a traves de manipulacion del gen v.
WO2003052082A3 (en) Fusion partner cells and uses thereof
EP1105426A4 (en) INHIBITOR OF MONOCLONAL ANTIBODIES TO GM-CSF, IL-3, IL-5 AND OTHER CYTOKINES, AS WELL AS ITS USE
IL162117A0 (en) Humanized collagen antibodies and methods utilizing the same
AU6943800A (en) Antibodies specific for fullerenes
EP0787743A3 (de) A3C6E2, ein monoklonaler Antikörper spezifisch für den humanen Stammzellfaktor (SCF)-Rezeptor
EP2088158A3 (en) Monoclonal antibody against the CCR5 chemokine receptor
NZ501990A (en) Compositions containing antigen-binding fragments that recognise the antigen recognised by a recombinant 4B5 antibody
GB0309126D0 (en) Clostridium difficile focussed antibodies
WO2004025293A3 (de) Antikörper zur isolierung und/oder identifizierung mesenchymaler stammzellen und verfahren zur isolierung und/oder identifizierung mesenchymaler stammzellen
DK1092767T3 (da) Serinproteasespecifikke monoklonale antistoffer og anvendelse deraf
GB2387847B (en) Method for producing monoclonal antibodies
WO2005049652A3 (en) Methods of generating antibody diversity in vitro
EP1468022A4 (en) NEW MONOCLONAL ANTIBODY AND LARVAL NEMATODIAN ANTIGENS
UA39209C2 (uk) Моноклональне антитіло, що інгібує хомінг кровотворних стовбурових клітин і розпізнає поверхневий антіген стромальної клітини селезінки, гібридома, яка його продукує
HUP0003029A2 (hu) Ankrod specifikus monoklonális antitestek, antitestfragmentumok, keverékeik és alkalmazásuk